These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25131220)

  • 1. Multi-omics analysis of inflammatory bowel disease.
    Huang H; Vangay P; McKinlay CE; Knights D
    Immunol Lett; 2014 Dec; 162(2 Pt A):62-8. PubMed ID: 25131220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of IBD Heritability: Genes, Bugs, and More.
    Turpin W; Goethel A; Bedrani L; Croitoru Mdcm K
    Inflamm Bowel Dis; 2018 May; 24(6):1133-1148. PubMed ID: 29701818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
    Hirata Y; Ihara S; Koike K
    Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-environment interactions in inflammatory bowel disease pathogenesis.
    Wang MH; Achkar JP
    Curr Opin Gastroenterol; 2015 Jul; 31(4):277-82. PubMed ID: 26039718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
    Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
    Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune aspects of the pathogenesis of inflammatory bowel disease.
    Hisamatsu T; Kanai T; Mikami Y; Yoneno K; Matsuoka K; Hibi T
    Pharmacol Ther; 2013 Mar; 137(3):283-97. PubMed ID: 23103332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic background of inflammatory bowel disease: from correlation to causality.
    Uniken Venema WT; Voskuil MD; Dijkstra G; Weersma RK; Festen EA
    J Pathol; 2017 Jan; 241(2):146-158. PubMed ID: 27785786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre.
    Hart AL; Hendy P
    Proc Nutr Soc; 2014 Nov; 73(4):452-6. PubMed ID: 25221893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiome in inflammatory bowel disease: current status and the future ahead.
    Kostic AD; Xavier RJ; Gevers D
    Gastroenterology; 2014 May; 146(6):1489-99. PubMed ID: 24560869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory bowel disease: between genetics and microbiota.
    Younis N; Zarif R; Mahfouz R
    Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-bacteria interaction in inflammatory bowel disease.
    Knight P; Campbell BJ; Rhodes JM
    Br Med Bull; 2008; 88(1):95-113. PubMed ID: 18931057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease: beyond the boundaries of the bowel.
    Actis GC; Rosina F; Mackay IR
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems biology in inflammatory bowel diseases: ready for prime time.
    Polytarchou C; Koukos G; Iliopoulos D
    Curr Opin Gastroenterol; 2014 Jul; 30(4):339-46. PubMed ID: 24837229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease.
    Häsler R; Sheibani-Tezerji R; Sinha A; Barann M; Rehman A; Esser D; Aden K; Knecht C; Brandt B; Nikolaus S; Schäuble S; Kaleta C; Franke A; Fretter C; Müller W; Hütt MT; Krawczak M; Schreiber S; Rosenstiel P
    Gut; 2017 Dec; 66(12):2087-2097. PubMed ID: 27694142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease.
    Basso PJ; Fonseca MT; Bonfá G; Alves VB; Sales-Campos H; Nardini V; Cardoso CR
    Braz J Med Biol Res; 2014 Sep; 47(9):727-37. PubMed ID: 25075576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrigenomics and nutrigenetics in inflammatory bowel diseases.
    Gruber L; Lichti P; Rath E; Haller D
    J Clin Gastroenterol; 2012 Oct; 46(9):735-47. PubMed ID: 22941427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.